Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2025-12-25 @ 2:16 AM
NCT ID:
NCT01413360
Eligibility Criteria:
Inclusion Criteria:
1. Chronic hepatitis C patients
* positive anti-HCV antibody more than 6 months
* serum alanine aminotransferase 40 - 80 IU/L for more than 6 months
* not indicated for antiviral therapy with interferon and ribavirin
2. Chronic alcoholic hepatitis
* significant alcohol drinking history and no other cause of chronic hepatitis
* serum alanine aminotransferase 40 - 80 IU/L for more than 6 months
Exclusion Criteria:
* Chronic hepatitis B, autoimmune hepatitis, primary biliary cirrhosis, Wilson's disease, hemochromatosis, other chronic hepatitis except chronic hepatitis C or alcoholic hepatitis
* decompensated liver cirrhosis
* platelet \< 50,000/uL or white blood cell \< 1,500/uL
* need and willing for antiviral therapy
* significant renal dysfunction (GFR \< 30 mL/min/kg) or history of renal stone
* hepatotonic drug (i.e. silymarin, garlic oil, aronamin gold) usage within 2 weeks
* pregnancy, lactating woman
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT01413360
Study Brief:
Protocol Section:
NCT01413360